Public filings / CGEM on Yahoo Finance (opens in a new tab)
CGEM: insider buying, 13F holders, analyst moves
Cullinan Therapeutics Inc - US
A summary of public filings about Cullinan Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
3 of our 100 managers hold CGEM
Combined reported value $51.2M; 1 sold out since Q1 2026.
Holders among our 100 managers: 1 in Q3 2023, 3 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RTW Investments | $43.1M | 0.37% | Added |
| Perceptive Advisors | $7.8M | 0.12% | New |
| Tudor Investment | $410K | 0.00% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.